Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00971334 · ClinicalTrials.gov registry record

Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker

A clinical trial of Pregnancy and Down Syndrome, sponsored by Sequenom.

Completed
Registry status
2,502
Enrollment target
20
Study locations

NCT00971334 is a study of Pregnancy and Down Syndrome that has completed, run by Sequenom. The registered enrollment target is 2,502 participants, above the 860-participant average among 191 other Pregnancy trials with a reported enrollment target (191% higher). The trial reports 20 study locations across 10 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00971334, a study of Pregnancy and Down Syndrome, has completed, sponsored by Sequenom.

COMPLETED
Registry status
2,502 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to collect samples for the purpose of developing a prenatal aneuploid test using circulating cell free fetal (ccff) nucleic acid from blood samples from pregnant women who have a high-risk pregnancy undergoing invasive prenatal diagnosis by chorionic villus sampling (CVS) and/or genetic amniocentesis. The results of the ccff aneuploid test will be compared to the chromosomal analysis obtained via CVS or amniocentesis.

Conditions Studied

Pregnancy Down Syndrome Aneuploidy Edwards Syndrome

Study Locations (20)

Florida

  • Visions Clinical Research - Boynton Beach
  • University of Miami - Miami
  • South Florida Perinatal Medicine - Miami
  • Global Ob/Gyn Centers - Pembroke Pines
  • Discovery Clinical Research - Sunrise
  • Sheridan Clinical Research - Sunrise

California

  • Grossmont Center for Clinical Research - La Mesa
  • IGO - San Diego
  • San Diego Perinatal Center - San Diego
  • Women's Healthcare at Frost Street - San Diego
  • Poway Womens Care - San Diego

Michigan

  • Spectrum Health - Maternal Fetal Medicine - Grand Rapids
  • William Beaumont Hospital - Royal Oak

Alabama

  • University of South Alabama - Mobile

Hawaii

  • Fetal Diagnostic Institution of the Pacific - Honolulu

Idaho

  • Women's Clinic - Boise

Illinois

  • Reproductive Genetics Institute - Chicago

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 2,502 participants
Start Date 2009-08
Est. Completion 2011-12

Sponsor

Sequenom

26 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00971334

The ClinicalTrials.gov registry entry for NCT00971334 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,502 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 860-participant average among 191 other Pregnancy trials with a reported enrollment target (191% higher). The listed sponsor is Sequenom, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Pregnancy appearing as the primary indexed condition, and to 0 interventions.

NCT00971334 reports 20 study locations spanning 10 distinct geographic areas - top geographies include Florida, California, Michigan.

Frequently Asked Questions

What is clinical trial NCT00971334 about?

NCT00971334 is a clinical study titled "Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker". The purpose of this study is to collect samples for the purpose of developing a prenatal aneuploid test using circulating cell free fetal (ccff) nucleic acid from blood samples from pregnant women who have a high-risk pregnancy undergoing invasive prenatal diagnosis by chorionic villus sampling (CVS...

What is the current status of trial NCT00971334?

This trial is currently completed. The enrollment target is 2,502 participants. The study started on 2009-08. Estimated completion is 2011-12.

What conditions does trial NCT00971334 study?

This clinical trial studies the following conditions: Pregnancy, Down Syndrome, Aneuploidy, Edwards Syndrome.

Who is sponsoring clinical trial NCT00971334?

This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00971334 being conducted?

This trial has 20 study locations across Alabama, California, Florida, Hawaii, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pregnancy

All registered trials for this condition

Down Syndrome

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.